ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
$14.47 0.39 (2.7699%)
Analysed ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) News Sources
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
15-04-2026
yahoo.com
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
08-04-2026
fool.com
A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements
05-04-2026
yahoo.com
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look
31-03-2026
fool.com
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year
26-03-2026
fool.com
Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price
26-03-2026
fool.com
Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?
16-03-2026
yahoo.com
Insider Sales Put Focus On Adaptive Biotechnologies Growth Story And Dilution Risk
06-03-2026
yahoo.com
Slingshot Biosciences Appoints Jim Snook as Senior Vice President, Global Sales
05-03-2026
yahoo.com
Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf.
03-03-2026
marketbeat.com
What is the current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The current price of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is $14.47.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is $0.39.
ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) since the previous trading day is 2.7699%.
What is the most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent average sentiment score for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)?
The most recent sentiment for ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ) is .
SEC-8K** Filing Available For ADAPTIVE BIOTECHNOLOGIES (ADPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.